Aerosol-Processed Thermosensitive Nanocomposites for Controlled Drug Release

Area of Science:

• Materials Science
• Nanotechnology
• Biomedical Engineering

Background:

• Controlled drug delivery systems are crucial for enhancing therapeutic efficacy and minimizing side effects.
• Iron nanoparticles offer unique magnetic properties for targeted applications.
• Thermosensitive polymers provide a mechanism for triggered drug release.

Purpose of the Study:

• To synthesize and characterize novel Fe@NIPAM-PDMS-DOX nanocomposites.
• To investigate the magnetothermal drug release capabilities of these nanocomposites.
• To evaluate the cytotoxic effects of the released doxorubicin on HeLa cells.

Main Methods:

• Ambient-spark production of Fe nanoparticles.
• Atomization of N-isopropylacrylamide (NIPAM)-polydimethylsiloxane (PDMS) solutions.
• Encapsulation of Fe nanoparticles within NIPAM-PDMS droplets.
• Incorporation of doxorubicin (DOX) into the nanocomposites.
• Magnetothermal stimulation for drug release studies.
• Cytotoxicity assays on HeLa cells.

Main Results:

• Successfully synthesized Fe@NIPAM-PDMS nanocomposites with a unimodal size distribution.
• Demonstrated tunable sizes and morphologies of nanocomposites by varying processing temperatures.
• Achieved quantitative incorporation of Fe nanoparticles and doxorubicin.
• Observed magnetothermal-triggered release of DOX from the nanocomposites.
• Showcased differential cytotoxic effects on HeLa cells correlating with DOX release.

Conclusions:

• Fe@NIPAM-PDMS-DOX nanocomposites are effective for magnetothermal-triggered drug delivery.
• The thermosensitivity and magnetic properties make them promising for targeted cancer therapy.
• These nanocomposites represent a significant advancement in controlled drug delivery systems.